A NIBR postdoctoral fellowship leads to the discovery of a key genetic mutation behind a form of blindness.
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
Sandoz, the generic division of Novartis, is working with a local partner in Brazil which is undertaking the first clinical trial in that country for a biosimilar drug.
GNF head spent career making scientific discoveries in academia. Read how he now he plans to evolve drug discovery in industry.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.